HomeCompareVLON vs NNN

VLON vs NNN: Dividend Comparison 2026

VLON yields 500.00% · NNN yields 5.66%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VLON wins by $61399.50M in total portfolio value
10 years
VLON
VLON
● Live price
500.00%
Share price
$0.40
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$61399.52M
Annual income
$44,063,578,515.70
Full VLON calculator →
NNN
NNN REIT Inc.
● Live price
5.66%
Share price
$42.03
Annual div
$2.38
5Y div CAGR
8.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.5K
Annual income
$2,622.67
Full NNN calculator →

Portfolio growth — VLON vs NNN

📍 VLON pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVLONNNN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VLON + NNN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VLON pays
NNN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VLON
Annual income on $10K today (after 15% tax)
$42,500.00/yr
After 10yr DRIP, annual income (after tax)
$37,454,041,738.34/yr
NNN
Annual income on $10K today (after 15% tax)
$481.32/yr
After 10yr DRIP, annual income (after tax)
$2,229.27/yr
At 15% tax rate, VLON beats the other by $37,454,039,509.08/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VLON + NNN for your $10,000?

VLON: 50%NNN: 50%
100% NNN50/50100% VLON
Portfolio after 10yr
$30699.77M
Annual income
$22,031,790,569.19/yr
Blended yield
71.77%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

VLON
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
36.7
Piotroski
2/9
NNN
Analyst Ratings
10
Buy
15
Hold
4
Sell
Consensus: Hold
Price Target
$44.93
+6.9% upside vs current
Range: $43.00 — $48.50
Altman Z
1.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VLON buys
0
NNN buys
0
No recent congressional trades found for VLON or NNN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVLONNNN
Forward yield500.00%5.66%
Annual dividend / share$2.00$2.38
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%8.6%
Portfolio after 10y$61399.52M$25.5K
Annual income after 10y$44,063,578,515.70$2,622.67
Total dividends collected$59892.67M$13.7K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyHold

Year-by-year: VLON vs NNN ($10,000, DRIP)

YearVLON PortfolioVLON Income/yrNNN PortfolioNNN Income/yrGap
1← crossover$60,700$50,000.00$10,735$614.96+$50.0KVLON
2$348,594$283,644.86$11,572$708.43+$337.0KVLON
3$1,895,372$1,522,376.89$12,531$819.53+$1.88MVLON
4$9,763,990$7,735,942.00$13,633$952.29+$9.75MVLON
5$47,691,977$37,244,507.54$14,909$1,111.84+$47.68MVLON
6$221,049,019$170,018,603.23$16,392$1,304.77+$221.03MVLON
7$972,993,924$736,471,474.07$18,129$1,539.52+$972.98MVLON
8$4,070,762,075$3,029,658,575.98$20,173$1,827.08+$4070.74MVLON
9$16,201,818,371$11,846,102,950.68$22,597$2,181.81+$16201.80MVLON
10$61,399,524,173$44,063,578,515.70$25,491$2,622.67+$61399.50MVLON

VLON vs NNN: Complete Analysis 2026

VLONStock

Vallon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medications for central nervous system disorders with a focus on abuse-deterrent medications. Its lead investigational product candidate is ADAIR, an abuse-deterrent oral formulation of immediate-release dextroamphetamine for the treatment of attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. The company is also developing ADMIR, an abuse deterrent formulation of methylphenidate for the treatment of ADHD. Vallon Pharmaceuticals, Inc. was incorporated in 2018 and is based in Philadelphia, Pennsylvania.

Full VLON Calculator →

NNNREIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →
📬

Get this VLON vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VLON vs SCHDVLON vs JEPIVLON vs OVLON vs KOVLON vs MAINVLON vs ADCVLON vs EPRTVLON vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.